Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VERTPAC-02: Verteporfin PDT in Pancreatic Tumors
NCT03033225Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- May 2017
- Primary completion
- Sep 2023
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of verteporfin in pancreatic cancer (PC), sponsored by Mayo Clinic. Started May 2017; status: completed.
02
Drugs
verteporfin
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT03033225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03033225.